Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Psoriatic Arthritis (HUPSA)
NCT01465438Phase 4Completed
- Sponsor
- Rigshospitalet Glostrup
- Start
- Nov 2006
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in psoriatic arthritis (PsA), sponsored by Rigshospitalet Glostrup. Started Nov 2006; status: completed.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT01465438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01465438.